Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
I

Instituto de Diagnostico SA
SGO:INDISA

Watchlist Manager
Instituto de Diagnostico SA
SGO:INDISA
Watchlist
Price: 2 717.7 CLP -2.75% Market Closed
Market Cap: 417B CLP
Write Note Create Alert Ask AI

Net Margin

4.3%
Current
Improving
by 2.3%
vs 3-y average of 2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.3%
=
Net Income
10.9B
/
Revenue
252.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.3%
=
Net Income
CLP10.9B
/
Revenue
252.7B

Peer Comparison

Market Distribution

In line with most companies in Chile
Percentile
51st
Based on 140 companies
51st percentile
4.3%
Low
-180.6% — 0%
Typical Range
0% — 9.8%
High
9.8% — 24 536.6%
Distribution Statistics
Chile
Min -180.6%
30th Percentile 0%
Median 4.1%
70th Percentile 9.8%
Max 24 536.6%

Other Profitability Ratios

Instituto de Diagnostico SA
Glance View

Market Cap
417B CLP
Industry
Health Care

Instituto de Diagnostico SA provides medical health care and insurance services. The firm manages and operates Clinica Indisa, a private clinic located in the Santiago Metropolitan Region, which provides such hospital and outpatient services, as internal medicine admission and surgery, intensive and intermediate care units, pediatrics and neonatology, post-surgery recuperation, clinical laboratories, blood donation, radiology, endocrinology, computerized tomography, magnetic resonance imaging (MRI), nuclear medicine, hemodialysis and other outpatient procedures and services that cover all areas of medicine. As of December 31, 2011, the Company owned such subsidiaries as Servicios Integrados de Salud Ltda, Servicios Complementarios de Salud Ltda, Inmobiliaria San Cristobal SA and Indisa Laboratorio Ltda.

INDISA Intrinsic Value
1 819.39 CLP
Overvaluation 33%
Intrinsic Value
Price
I
What is Intrinsic Value?

See Also

Summary
INDISA intrinsic value, competitors valuation, and company profile.
DCF Valuation
INDISA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INDISA stock valuation using valuation multiples.
Wall Street Estimates
INDISA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INDISA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
4.3%
=
Net Income
10.9B
/
Revenue
252.7B
What is Instituto de Diagnostico SA's current Net Margin?

The current Net Margin for Instituto de Diagnostico SA is 4.3%, which is above its 3-year median of 2%.

How has Net Margin changed over time?

Over the last 3 years, Instituto de Diagnostico SA’s Net Margin has decreased from 11.3% to 4.3%. During this period, it reached a low of -0.8% on Sep 30, 2023 and a high of 11.3% on Jun 30, 2022.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.